The DOI matches its Crossref record; 18 of the 18 references it cites were found in a registry or an index.
Experience with a once-daily aminoglycoside program administered to 2,184 adult patients
Open accessAbstract
Once-daily aminoglycoside (ODA) regimens have been instituted to maximize bacterial killing by optimizing the peak concentration/MIC ratio and to reduce the potential for toxicity. We initiated an ODA program at our institution that utilizes a fixed 7-mg/kg intravenous dose with a drug administration interval based on estimated creatinine clearance: > or = 60 ml/min every 24 h (q24h), 59 to 40 ml/min q36h, and 39 to 20 ml/min q48h. Subsequent interval adjustments are made by using a single concentration in serum and a nomogram designed for monitoring of ODA therapy. Since initiation of the program, 2,184 patients have received this ODA regimen. The median dose was 450 (range, 200 to 925) mg, while the median length of therapy was 3 (range, 1 to 26) days. The median age of the population was 46 (range, 13 to 97) years. Gentamicin accounted for 94% of the aminoglycoside use, and the majority (77%) of patients received the drug q24h. The 36-, 48-, and > 48-h intervals were used for 15, 6, and 2% of this population, respectively. Three patients exhibited clinically apparent ototoxicity. Twenty-seven patients (1.2%) developed nephrotoxicity (the Hartford Hospital historical rate is approximately 3 to 5%) after a median of 7 (range, 3 to 19) days of therapy. On the basis of a prospective evaluation of 58 patients and follow-up of additional patients via clinician reports, we have noted no apparent alterations in clinical response with our ODA program. This ODA program appears to be clinically effective, reduces the incidence of nephrotoxicity, and provides a cost-effective method for administration of aminoglycosides by reducing ancillary service time and serum aminoglycoside determinations.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Prediction of Creatinine Clearance from Serum Creatinine
Cockcroft, D. W., & Gault, H. (1976) · Nephron · doi:10.1159/000180580 · Cited by 15,309
Moore, R. D., Lietman, P. S., & Smith, C. R. (1987) · Journal of Infectious Diseases · doi:10.1093/infdis/155.1.93 · Cited by 1,139
Mechanism of bactericidal action of aminoglycosides
Davis, B. D. (1987) · Microbiological Reviews · doi:10.1128/mmbr.51.3.341-350.1987 · Cited by 620
Blaser, J., Stone, B. B., Groner, M. C., & Zinner, S. H. (1987) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.31.7.1054 · Cited by 481
Sawchuk, R. J., & Zaske, D. E. (1976) · Journal of Pharmacokinetics and Biopharmaceutics · doi:10.1007/bf01086153 · Cited by 361
Once versus thrice daily gentamicin in patients with serious infections
Prins, J. M., Buller, H. R., Speelman, P., Kuijper, E. J., & Tange, R. A. (1993) · The Lancet · doi:10.1016/0140-6736(93)90137-6 · Cited by 350
Once-daily aminoglycoside therapy
Gilbert, D. N. (1991) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.35.3.399 · Cited by 324
Killing and regrowth of bacteria in vitro: a review.
Craig, W. A., & Ebert, S. C. (1990) · PubMed · Cited by 303
Bennett, W. M., Plamp, C. E., Gilbert, D. N., Parker, R. A., & Porter, G. A. (1979) · Journal of Infectious Diseases · doi:10.1093/infdis/140.4.576 · Cited by 183
ter Braak, E. W. M. T., de Vries, P. J., Bouter, K. P., van der Vegt, S. G. L., Gc, D., Nortier, J. W. R., van Dijk, A. P. J., Verkooyen, R. P. A. J., & Verbrugh, H. A. (1990) · The American Journal of Medicine · doi:10.1016/0002-9343(90)90099-y · Cited by 148
A Critical Reevaluation of the "Therapeutic Range" of Aminoglycosides
McCormack, J. P., & Jewesson, P. J. (1992) · Clinical Infectious Diseases · doi:10.1093/clinids/14.1.320 · Cited by 146
Zaske, D. E., Cipolle, R. J., & Strate, R. J. (1980) · PubMed · Cited by 116
Does administration of an aminoglycoside in a single daily dose affect its efficacy and toxicity?
Nordström, L., Ringbert, H., Cronberg, S., Tjernström, Ö., & Walder, M. (1990) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/25.1.159 · Cited by 107
Netilmicin in the Treatment of Gram-Negative Bacteremia: Single Daily versus Multiple Daily Dosage
Sturm, A. W. (1989) · The Journal of Infectious Diseases · doi:10.1093/infdis/159.5.931 · Cited by 101
Pharmacodynamic Properties of Antibiotics: Application to Drug Monitoring and Dosage Regimen Design
Ebert, S. C., & Craig, W. A. (1990) · Infection Control and Hospital Epidemiology · doi:10.1086/646178 · Cited by 91
de Vries, P. J., Verkooyen, R. P. A. J., Leguit, P., & Verbrugh, H. A. (1990) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/bf01963832 · Cited by 76
Edson, R., & Terrell, C. L. (1987) · Mayo Clinic proceedings · doi:10.1016/s0025-6196(12)65048-4 · Cited by 40
Pharmacokinetic Monitoring of Nephrotoxic Antibiotics in Surgical Intensive Care Patients
Reed, R. L., WU, A. H., MILLER-CROTCHETT, P., Crotchett, J., & Fischer, R. P. (1989) · The Journal of Trauma: Injury, Infection, and Critical Care · doi:10.1097/00005373-198911000-00002 · Cited by 37
Cited by
Habib, G., Lancellotti, P., Antunes, M. J., Bongiorni, M. G., Casalta, J.-P., Del Zotti, F., Dulgheru, R., El Khoury, G., Erba, P. A., Iung, B., et al. (2015) · European Heart Journal · doi:10.1093/eurheartj/ehv319 · Cited by 4,997
Clinical practice guidelines for antimicrobial prophylaxis in surgery
Bratzler, D. W., Dellinger, E. P., Olsen, K. M., Perl, T. M., Auwaerter, P. G., Bolon, M. K., Fish, D. N., Napolitano, L. M., Sawyer, R. G., Slain, D., et al. (2013) · American Journal of Health-System Pharmacy · doi:10.2146/ajhp120568 · Cited by 2,591
Guidelines on the prevention, diagnosis, and treatment of infective endocarditis (new version 2009)
Endorsed by the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) and by the International Society of Chemotherapy (ISC) for Infection and Cancer, Habib, G., Hoen, B., Tornos, P., Thuny, F., Prendergast, B., Vilacosta, I., Moreillon, P., de Jesus Antunes, M., Thilen, U., et al. (2009) · European Heart Journal · doi:10.1093/eurheartj/ehp285 · Cited by 2,014
Baddour, L. M., Wilson, W. R., Bayer, A. S., Fowler, V. G., Bolger, A. F., Levison, M. E., Ferrieri, P., Gerber, M. A., Tani, L. Y., Gewitz, M. H., et al. (2005) · Circulation · doi:10.1161/circulationaha.105.165564 · Cited by 1,707
Clinical Practice Guidelines for Antimicrobial Prophylaxis in Surgery
Bratzler, D. W., Dellinger, E. P., Olsen, K. M., Perl, T. M., Auwaerter, P. G., Bolon, M. K., Fish, D. N., Napolitano, L. M., Sawyer, R. G., Slain, D., et al. (2013) · Surgical Infections · doi:10.1089/sur.2013.9999 · Cited by 1,197
Metadata
- Authors
- Nicolau, D. P., Freeman, C. D., Belliveau, P. P., Nightingale, C. H., Ross, J. W., & Quintiliani, R.
- Venue
- Antimicrobial Agents and Chemotherapy
- Publisher
- American Society for Microbiology
- Published
- 1995-03
- Volume
- 39
- Issue
- 3
- Pages
- 650-655
- ISSN
- 0066-4804 (ISSN-L)
- 1098-6596
- OpenAlex
- W2100907980
- Cited by
- 641
- References
- 18
- FWCI
- 21.88
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.